|
|
Northwest Biotherapeutics Inc.
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
|
return to message board, top of board |
Re: O'Brien-Fleming spendinf functionBy itself it more than doubles the odds of living to 5 years with GBM. You and the company have zero data to back this up because there is no legitimate control arm showing this. The only legit comparison data they have shows mOS going down when they remove the ACTUAL trial control patients. Anything done at UCLA will have to go through the clinical trial process just like every other approved drug/biologic. But hey, sell a boat and buy more cheapies. Remember they were cheap at $5-7 according to the iHub idiots. |
||||||||||||
|
|
return to message board, top of board |
| Msg # | Subject | Author | Recs | Date Posted |
| 16740 | Re: O'Brien-Fleming spendinf function | GaryM | 3 | 9/19/2023 2:37:29 PM |
| 16741 | Re: O'Brien-Fleming spendinf function | co3aii | 0 | 9/19/2023 2:42:19 PM |
